SCHEMBL1228108

SCHEMBL1228108

COc1ccc(-c2ccc(/C=C3/N=C(N)N(C)C3=O)o2)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTRA2 O43464 1/20 0.55
▸ MAPT P10636 5/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ KMT2A Q03164 4/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ HPGD P15428 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ GSK3A P49840 3/20 0.40
▸ GSK3B P49841 3/20 0.40
▸ CLK1 P49759 2/20 0.40
▸ CLK2 P49760 2/20 0.40
▸ DYRK2 Q92630 2/20 0.40
▸ DYRK3 O43781 1/20 0.40
▸ DYRK1A Q13627 1/20 0.40
▸ LTB4R Q15722 1/20 0.40
▸ CLK4 Q9HAZ1 1/20 0.40
▸ DYRK4 Q9NR20 1/20 0.40
▸ DYRK1B Q9Y463 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1228111 1.00 HTRA2 (0.55) HTRA2MAPTALDH1A1KDM4EKMT2A
SCHEMBL1116054 0.88 HTRA2 (0.52) HTRA2MAPTALDH1A1KDM4EKMT2A
SCHEMBL1116057 0.88 HTRA2 (0.52) HTRA2MAPTALDH1A1KDM4EKMT2A
SCHEMBL1116267 0.85 HTRA2 (0.57) HTRA2MAPTALDH1A1KDM4EKMT2A
SCHEMBL1116263 0.85 HTRA2 (0.57) HTRA2MAPTALDH1A1KDM4EKMT2A
SCHEMBL1227354 0.84 MAPT (0.50) HTRA2MAPTALDH1A1KDM4EKMT2A
SCHEMBL1227358 0.84 MAPT (0.50) HTRA2MAPTALDH1A1KDM4EKMT2A
SCHEMBL1228307 0.84 HTRA2 (0.47) HTRA2MAPTALDH1A1KDM4EKMT2A
SCHEMBL1228304 0.84 HTRA2 (0.47) HTRA2MAPTALDH1A1KDM4EKMT2A
SCHEMBL1228154 0.83 HTRA2 (0.49) HTRA2MAPTALDH1A1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011015646-A2 FURAN-IMIDAZOLONE DERIVATIVES, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS NOSCIRA, S.A. (ES) 2011-02-10 — — WO disclosed
EP-2281824-A1 Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders NOSCIRA, S.A. (ES) 2011-02-09 — — EP disclosed
Send feedback